← FDA Drug Approvals (Drugs@FDA)
DOCOSANOL
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: P AND L DEVELOPMENT · Approved 2022-10-07
Drug application
- FDA Application #
ANDA212385- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOCOSANOL
- Generic name
- DOCOSANOL
- Active ingredients
- DOCOSANOL
- Dosage form
- CREAM
- Route
- TOPICAL
- Marketing status
- Over-the-counter
- Sponsor
- P AND L DEVELOPMENT
- Manufacturer
- H2-Pharma, LLC
- First approval
- 2022-10-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown